Previous studies showed an inverse correlation between EZH2 and MHC class I antigen presentation molecule expression levels in squamous cell carcinomas, such as head, neck, and lung squamous cell carcinoma [47]. The gene discussed is EZH2; the disease is squamous cell lung carcinoma.